WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- not in favor of (an action or proposal etc.)
- a person who is opposed (to an action or policy or practice etc.); "the antis smelled victory after a long battle"
- social insect living in organized colonies; characteristically the males and fertile queen have wings during breeding season; wingless sterile females are the workers (同)emmet, pismire
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
- 《話》(特定の慣習・政策・行動などに)反対する人
- 『アリ』
- =ain't
- (次にくる語の発音が母音で始まるときに用いる) / (子音[h]で始まり第1音節に強勢のない語の場合はanを用いることがある.ただし,この場合は[h]を発音しない)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 薬物誘発性ループス drug induced lupus
- 2. 成人におけるステロイド抵抗性およびステロイド依存性の潰瘍性大腸炎に対するアプローチ approach to adults with steroid refractory and steroid dependent ulcerative colitis
- 3. 手術不能な転移性大腸癌に対する全身化学療法：治療に関する推奨 systemic chemotherapy for nonoperable metastatic colorectal cancer treatment recommendations
- 4. 転移性の胃腸系神経内分泌腫瘍（カルチノイド）：腫瘍増殖およびホルモン過剰分泌による症状を管理するための全身治療の選択肢 metastatic gastrointestinal neuroendocrine carcinoid tumors systemic therapy options to control tumor growth and symptoms of hormone hypersecretion
- 5. クローン病の内科的マネージメントにおける試験研究治療 investigational therapies in the medical management of crohn disease
English Journal
- Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration.
- Chen Y1, Liu G, Guo L, Wang H, Fu Y, Luo Y.
- International journal of cancer. Journal international du cancer.Int J Cancer.2015 Jan 1;136(1):182-94. doi: 10.1002/ijc.28950. Epub 2014 May 14.
- Cetuximab, a monoclonal antibody (mAb) targeting the epidermal growth factor receptor (EGFR), has been intensively investigated as a promising cancer treatment strategy. The specific mechanism of cetuximab endocytosis and its influence on cetuximab uptake, biodistribution and efficacy still remain e
- PMID 24798787
- Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.
- Yoon SO1, Zapata MC, Singh A, Jo WS, Spencer N, Choi YS.
- Apoptosis : an international journal on programmed cell death.Apoptosis.2014 Nov;19(11):1616-26. doi: 10.1007/s10495-014-1029-5.
- Activating mutations in the NOTCH1 gene are found in over 50 % of T-ALL cases. Since Notch signaling contributes to the leukemia cell survival and growth, targeting Notch signaling using γ-secretase inhibitors (GSI) has been proposed as a molecularly targeted therapy for the treatment of T-ALL. Ho
- PMID 25156146
- Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States.
- Curtis JR1, Zhang J, Xie F, Beukelman T, Chen L, Fernandes J, Ginsberg S, Spettell C, Yun H, Saag KG, Schiff M.
- Arthritis care & research.Arthritis Care Res (Hoboken).2014 Nov;66(11):1604-11. doi: 10.1002/acr.22383.
- OBJECTIVE: To examine the patterns of methotrexate (MTX) use among rheumatoid arthritis (RA) patients.METHODS: Using data from RA patients enrolled in a US commercial health plan and the US Medicare program, we identified RA patients initiating oral MTX. Persistence with MTX (oral or subcutaneous [S
- PMID 24942466
Japanese Journal
- Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
- BMC cancer 16, 455, 2016-07
- NAID 120005829742
- An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
- SpringerPlus 5, 195, 2016-02
- NAID 120005753018
- 造血器悪性腫瘍に対する免疫チェックポイント阻害薬
- 臨床血液 57(11), 2381-2387, 2016
- NAID 130005433510
Related Pictures
★リンクテーブル★
| リンク元 | 「antitumor drug」「antitumor agent」「anti-tumor drug」 |
| 関連記事 | 「agent」「age」「ant」「tumor」「anti」 |
「antitumor drug」
- 関
- anti-tumor agent、anti-tumor drug、antineoplastic、antineoplastic agent、antineoplastic drug、antitumor agent
「antitumor agent」
- 関
- anti-tumor agent、anti-tumor drug、antineoplastic、antineoplastic agent、antineoplastic drug、antitumor drug
「anti-tumor drug」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する
「ant」
- n.
- 同
- ants, stinging
「tumor」
- n.
「anti」
- comb form.